Serum Institute along with the world’s largest vaccine maker is ramping up production of AstraZeneca Plc’sto have 10 crore Oxford covid vaccine ready by December for an inoculation drive that could begin across India that same month. If the final stage trial data of the Oxford-AstraZeneca’s Covid-19 vaccine candidate give effective protection from the coronavirus, Serum Institute of India may get emergency approval from the central government by next month. Poonawalla, according to a Bloomberg report, said that the initial amount of vaccine shots will be produced for India, but distributed on a 50-50 basis between New Delhi and Covax, which is buying the doses for poor nations and has the WHO backing. India is among the countries in Asia that is struggling to suppress the coronavirus as their economies bear the brunt of movement restrictions that have failed to stem the outbreak. Out of India’s 1.3 billion population, more than 8 million have been infected.
